Investment boutique Antipodes Partners has launched new investment vehicles for its existing global equity strategies for SMSF trustees and other retail investors.
Antipodes Partners also announced Andrew Findlay as its new managing director and the appointment of three new investment team members.
The firm’s new actively managed exchange-traded fund, also known as an exchange-quoted managed fund, will enable SMSFs and other retail investors to access Antipodes’ capabilities through an open-ended Australian Securities Exchange (ASX)-listed investment.
It has also launched Irish-domiciled UCITS funds for its global equity strategies, which target investors in Europe and Asia, where there is demand for the firm’s high-conviction, risk-aware approach.
“The investment team has the advantage of managing a focused number of investment strategies,” Findlay said.
“At the same time we are developing new vehicles to provide access to a broader spectrum of investors, both in Australia and overseas.”
Antipodes Partners, which has $7 billion in assets under management, appointed Findlay as managing director to oversee its business activities. He was previously a senior executive at minority partner Pinnacle Investment Management.
The firm has also appointed Kieran Rabbitt as an investment specialist responsible for portfolio analytics and systems development, Aidan Kerr as an investment analyst covering the global healthcare sector and Vinayak Muralidharan as an investment analyst covering the global financials and infrastructure sector.
Antipodes Partners opened its first listed investment company in 2016, seeking to address risks associated with SMSFs’ high allocations to Australian equities.
The firm’s Antipodes Global Investment Company exceeded $220 million in subscriptions in September 2016 and reported an after-tax profit of $26.8 million for the period to 30 June 2017.